Anupam Rasayan India Ltd (ANURAS) — Board Meeting | 23 September 2026

23 September 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Board approved execution of security documents for INR 300 crore debenture issuance by MVCPL.

🔄 What Changed

Approval of security documents enabling up to INR 300 crore debt financing via MVCPL.

🔮 What's Next

None

💡 Investor Takeaway

The company is leveraging its subsidiary to raise debt for strategic acquisitions, creating potential future dilution risk if the call option is exercised.

Anupam Rasayan India announced execution of key security documents related to a proposed INR 300 crore debenture issuance by its wholly owned subsidiary MVCPL. The documents include a debenture trust deed with Catalyst Trusteeship, a corporate guarantee from the parent company, a pledge over MVCPL's equity shares, and a call option agreement granting Purebliss an option to acquire MVCPL's stake at INR 1.00 per share. These arrangements support MVCPL's acquisition of Bliss GVS Pharma securities and general corporate purposes.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ANURAS ✨ Ask AI About This

About Anupam Rasayan India Ltd (ANURAS)

Chemicals · Chemicals · Listed on BSE

Market Cap: ₹13,509.81 CrP/E: 60.0ROE: 5.3%ROCE: 8.3%Div Yield: 0.13%

View full ANURAS stock details →

📡 Get AI alerts when ANURAS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ANURAS — Free

💡 Ask AI about this filing

"What is the expected interest rate on the INR 300 crore debentures?""When will the call option on MVCPL shares become exercisable?""How will the debt financing impact Anupam Rasayan's credit rating?"

Ask AI Free →

📊 More ANURAS filings

🔴 Corporate Action — 28 September 2026Anupam Rasayan India announced it acquired an additional 2.12% stake in Bliss GVS Pharma through a 2...
🔴 Announcement — 28 September 2026Anupam Rasayan India announced it has completed the acquisition of Bliss GVS Pharma for ₹299 per sha...
Announcement — 28 September 2026Anupam Rasayan India Ltd announced that its trading window will close on October 1, 2026, and remain...
🔴 Corporate Action — 21 September 2026Anupam Rasayan India announced the allotment of 14,500 senior secured rated unlisted redeemable non-...
🟡 Board Meeting — 19 September 2026Anupam Rasayan approved issuing up to 16,000 secured NCDs worth **₹160 crores** on September 19, 202...

See all ANURAS filings →

🔥 Also filed on 23 September 2026

PFOCUSPrime Focus LtdAnnouncement 501261Lords Mark Industries LimitedAnnouncement GREENPOWEROrient Green Power Company LtdCorporate Action PFOCUSPrime Focus LtdAnnouncement GSFCGujarat State Fertilizers & Chemicals LtdAnnouncement GLENMARKGlenmark Pharmaceuticals LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ANURAS files new disclosures

Track ANURAS filings, board meetings, and corporate actions. Free email alerts at 5 PM.